Literature DB >> 14021638

Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy.

B E CLAYTON, K M WILSON, C O CARTER.   

Abstract

Entities:  

Keywords:  ALDOLASE; MUSCULAR DYSTROPHY

Mesh：

Substances：

Year:  1963        PMID： 14021638      PMCID： PMC2019036          DOI： 10.1136/adc.38.199.208

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  11 in total

1.  Glycogenolytic enzymes in human progressive muscular dystrophy.

Authors:  G SCHAPIRA; J C DREYFUS; F SCHAPIRA; J KRUH
Journal:  Am J Phys Med       Date:  1955-02

2.  An investigation of the carrier state in the Duchenne type muscular dystrophy.

Authors:  P LEYBURN; W H THOMSON; J N WALTON
Journal:  Ann Hum Genet       Date:  1961-05       Impact factor: 1.670

3.  Serum enzymes and genetic carriers in muscular dystrophy.

Authors:  C S CHUNG; N E MORTON; H A PETERS
Journal:  Am J Hum Genet       Date:  1960-03       Impact factor: 11.025

4.  Activity of serum aldolase and lactic dehydrogenase in patients affected with Duchenne muscular dystrophy and in their immediate relatives.

Authors:  H C SOLTAN; M C BLANCHAER
Journal:  J Pediatr       Date:  1959-01       Impact factor: 4.406

5.  Muscular dystrophy in childhood; the genetic aspect; a field study in the Leeds region of clinical types and their inheritance.

Authors:  H BLYTH; R J PUGH
Journal:  Ann Hum Genet       Date:  1959-04       Impact factor: 1.670

6.  Serum enzymes in carriers of muscular dystrophy.

Authors:  B P HUGHES
Journal:  Br Med J       Date:  1962-10-13

7.  Serum aldolase in the neonatal period: including a colorimetric determination of aldolase by standardization with dihydroxyacetone.

Authors:  M M FRIEDMAN; B LAPAN
Journal:  J Lab Clin Med       Date:  1958-05

8.  Serum aldolase and the diagnosis of myopathy.

Authors:  R W BAKER; J H EVANS
Journal:  Brain       Date:  1957-12       Impact factor: 13.501

9.  [Genetics of myopathy].

Authors:  P E BECKER
Journal:  Dtsch Z Nervenheilkd       Date:  1955

10.  The clinical significance of serum aldolase.

Authors:  J A SIBLEY; G A FLEISHER
Journal:  Proc Staff Meet Mayo Clin       Date:  1954-11-10
View more
  7 in total

1.  CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

Authors:  K M WILSON; K A EVANS; C O CARTER
Journal:  Br Med J       Date:  1965-03-20

2.  [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. 3. RECESSIVE X-CHROMOSOMAL MUSCULAR DYSTROPHY WITH RELATIVELY BENIGN COURSE].

Authors:  H W ROTTHAUWE; S KOWALEWSKI
Journal:  Klin Wochenschr       Date:  1965-02-01

3.  [Contribution on the study of pseudohypertrophic muscular dystrophies. I. Benign pseudohypertrophic muscular dystrophy].

Authors:  H Radu; K Stenzel
Journal:  Dtsch Z Nervenheilkd       Date:  1969

4.  [Biochemical, histological and clinical findings in a four-year-old female carrier of benign X-linked muscular dystrophy (Becker type)].

Authors:  H Moser
Journal:  Humangenetik       Date:  1971

5.  Alpha-hydroxybutyrate dehydrogenase activity in sex-linked muscular dystrophy.

Authors:  H A Johnston; J H Wilkinson; W A Withycombe; S Raymond
Journal:  J Clin Pathol       Date:  1966-05       Impact factor: 3.411

6.  [A benign recessiv X-chromosomal hereditary muscular dystrophy. II. Examinations of female carriers].

Authors:  H W Rotthauwe; S Kowalewski
Journal:  Humangenetik       Date:  1966

7.  [Progressive muscular dystrophy. VII. Detection of heterozygotes of Duehenne muscular dystrophy by determining serum creatine kinase with localized work load in anoxia].

Authors:  U Wiesmann; H Moser; R Richterich; E Rossi
Journal:  Klin Wochenschr       Date:  1965-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.